Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 5, 2013

Aeterna Zentaris, Alcobra, CEL-SCI, Genkyotex, ImmunoGen, Immunomedics, Keryx, Omeros, OncoMed, Repros, Reviva, Serodus, Shire

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Omeros gets good results for AMD mAb . . . read more Phase I ImmunoGen starts ADC trial . . . read more OncoMed hits dose escalation milestone . . . read more Phase II Alcobra completes ADHD enrollment . . . read more Genkyotex starts NOX inhibitor trial . . . read more Keryx hits targets in NDD-CKD trial . . . read more Serodus enrolls patients for ISH trial . . . read more Phase III CEL-SCI receives positive safety news for Multikine trial . . . read more Reviva cleared to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters